CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Fujian Cosunter Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 30, 2020Pyridone Compound As C-Met Inhibitor1

Top competitors of Fujian Cosunter Pharmaceutical

List of top competitors of Fujian Cosunter Pharmaceutical based on patent oppositions.